Skip to main content

Table 1 Clinical and pathological characteristics

From: Hybrid ileal pouch with concomitant anti-refluxing and refluxing ureteroileal anastomosis

  Group A (N = 17) Group B (N = 8) Total (N = 25) p
Age (years) 63.4 ± 7.8
[59.0; 67.0]
60.0 ± 12.0
[50.5; 69.0]
62.3 ± 9.3
[57.5; 67.0]
0.410
Male gender 15 (88.2%) 7 (87.5%) 22 (88.0%) 1.000
Height 165.0 ± 7.9
[161.0; 170.8]
165.5 ± 4.9
[162.7; 169.6]
165.2 ± 7.0
[160.1; 169.7]
0.887
Weight 66.6 ± 8.7
[60.2; 75.3]
64.7 ± 12.8
[56.8; 76.8]
66.0 ± 9.9
[60.2; 76.0]
0.665
Body mass index (kg/m2) 24.5 ± 3.5
[21.6; 26.4]
22.8 ± 3.5
[20.5; 26.4]
24.0 ± 3.5
[21.3; 26.4]
0.293
Diabetes mellitus 3 (17.6%) 2 (25.0%) 5 (20.0%) 1.000
Hypertension 6 (35.3%) 2 (25.0%) 8 (32.0%) 0.956
Clinical T stage     0.571
 ≤ T2 7 (41.2%) 5 (62.5%) 12 (48.0%)  
 ≥ T3 10 (58.8%) 3 (37.5%) 13 (52.0%)  
Clinical lymph node positive 3 (17.6%) 1 (12.5%) 4 (16.0%) 1.000
Preoperative grade     0.544
G2 3 (20.0%) 0 (0.0%) 3 (12.0%)  
G3 12 (80.0%) 7 (100.0%) 19 (76.0%)  
Neoadjuvant chemotherapy 1 (5.9%) 2 (25.0%) 3 (12.0%) 0.476
  1. Mean ± standard deviation; []: Interquartile range